Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?

Ikeda, Hiroki; Okuse, Chiaki; Watanabe, Tsunamasa; Matsumoto, Nobuyuki; Matsunaga, Kotaro; Shigefuku, Ryuta; Hattori, Nobuhiro; Hiraishi, Tetsuya; Fukuda, Yasunobu; Noguchi, Yoshiko; Ishii, Toshimasa; Shima, Junko; Nakahara, Kazunari; Yamamoto, Hiroyuki; Yasuda, Hiroshi; Yotsuyanagi, Hiroshi; Koike, Kazuhiko; Itoh, Fumio; Suzuki, Michihiro

doi:10.5152/tjg.2016.150300

Turk J Gastroenterol

2016

DOI: 10.5152/tjg.2016.150300

|View full text |Cite

Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?

Hiroki Ikeda

Chiaki Okuse

Tsunamasa Watanabe³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2020

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?

Cited by 1 publication

References 32 publications

An innovative electrochemical platform for the sensitive determination of the hepatitis B inhibitor Entecavir with ionic liquid as a mediator

An innovative electrochemical platform for the sensitive determination of the hepatitis B inhibitor Entecavir with ionic liquid as a mediator

Contact Info

Product

Resources

About